The global market for point-of-care cholesterol monitoring devices is set for significant growth, with projections indicating a rise from USD 440.6 million in 2022 to USD 514.7 million by 2028. This growth, reflecting a steady compound annual growth rate (CAGR) of 2.6%, comes in response to the growing need for efficient, convenient, and accurate cholesterol …